ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,738.17
-0.13%
US Tech 100
19,439.97
-0.71%
Dow Jones
42,313.00
0.33%
Brent Oil
72.01
1.49%
Bitcoin
65,890.69
1.09%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Oxford Biomedica Plc (OXB) Quote

Oxford Biomedica Plc

Oxford Biomedica Plc (OXB)

LSE
381.50
2.00
(0.53%)
Closed September 27 11:30AM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
381.50
Bid
380.00
Ask
383.00
Volume
196,233
375.50 Day's Range 390.00
164.40 52 Week Range 394.00
Market Cap
401.878M
Previous Close
379.50
Open
382.00
Last Trade
20616
@
381.5
(UT)
Last Trade Time
Financial Volume
751,694p
VWAP
383.0618
Average Volume (3m)
143,455
Shares Outstanding
105,341,569
Dividend Yield
-
PE Ratio
-2.19
Earnings Per Share (EPS)
-1.75
Revenue
89.54M
Net Profit
-184.16M

About Oxford Biomedica Plc

Sector
Medicinal Chems,botanicl Pds
Industry
Medicinal Chems,botanicl Pds
Website
www.oxb.com
Headquarters
Oxford, Gbr
Founded
-
Oxford Biomedica Plc is listed in the Medicinal Chems,botanicl Pds sector of the London Stock Exchange with ticker OXB. The last closing price for Oxford Biomedica was 379.50p. Over the last year, Oxford Biomedica shares have traded in a share price range of 164.40p to 394.00p.

Oxford Biomedica currently has 105,341,569 shares outstanding. The market capitalization of Oxford Biomedica is £399.77 million. Oxford Biomedica has a price to earnings ratio (PE ratio) of -2.19.

Ask ADVFN Intelligence (AI)

OXB Latest News

More News

Interim Results for the Six Months Ended 30 June 2024

Press release OXFORD BIOMEDICA PLCINTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2024 Delivering Pure-Play CDMO Growth Strategy Continued execution of "One OXB" strategy with global...

September 23 2024
GlobeNewswire Inc.

Oxford Biomedica PLC Interim Results

Oxford Biomedica PLC 23 September 2024   Press release     OXFORD BIOMEDICA PLC INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2024 Delivering Pure-Play CDMO Growth Strategy •   Continued...

September 23 2024
RNS Regulatory News

Oxford Biomedica rebrands as OXB reinforcing transformation into leading global cell and gene therapy CDMO

Oxford Biomedica rebrands as OXB reinforcing transformation into leading global cell and gene therapy CDMO Oxford, UK – 18 September 2024: OXB (LSE:OXB), a quality and innovation-led cell and...

September 18 2024
GlobeNewswire Inc.

Oxford Biomedica PLC Oxford Biomedica rebrands as OXB

Oxford Biomedica PLC 18 September 2024     Press release     Oxford Biomedica rebrands as OXB reinforcing transformation into leading global cell and gene therapy CDMO Oxford, UK - 18...

September 18 2024
RNS Non-Regulatory

Lucinda Crabtree joins Oxford Biomedica as Chief Financial Officer today

Lucinda Crabtree joins Oxford Biomedica as Chief Financial Officer today Oxford, UK – 2 September 2024: Oxford Biomedica plc (LSE:OXB) (“Oxford Biomedica”, "OXB" or “the Company”), a quality and...

September 02 2024
GlobeNewswire Inc.

Oxford Biomedica PLC Lucinda Crabtree joins OXB as CFO today

Oxford Biomedica PLC 02 September 2024         Lucinda Crabtree joins Oxford Biomedica as Chief Financial Officer today Oxford, UK - 2 September 2024: Oxford Biomedica plc (LSE:OXB) ("Oxford...

September 02 2024
RNS Regulatory News

Oxford Biomedica PLC Total Voting Rights

Oxford Biomedica PLC 02 September 2024   Oxford Biomedica Total Voting Rights     Oxford, UK - 02 September 2024: Oxford Biomedica plc (LSE:OXB) ("Oxford Biomedica" or "the Company"), a...

September 02 2024
RNS Regulatory News

Oxford Biomedica to host a free webinar showcasing its AAV expertise

Oxford Biomedica to host a free webinar showcasing its AAV expertise Oxford, UK - 27 August 2024: On Wednesday 11 September 2024, Oxford Biomedica, a quality and innovation-led cell and gene...

August 27 2024
GlobeNewswire Inc.

Oxford Biomedica PLC Director Declaration

Oxford Biomedica PLC 09 August 2024         Oxford Biomedica Directorship notification under UK Listing Rule 6.4.9 (2)   Oxford, UK - 9 August 2024:  Oxford Biomedica plc (LSE:OXB) ("Oxford...

August 09 2024
RNS Regulatory News

Aligos Therapeutics Strengthens Board with Two New Independent Directors

SOUTH SAN FRANCISCO, Calif., Aug. 08, 2024 (GLOBE NEWSWIRE) --  Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”, the “Company”), a clinical stage biopharmaceutical company focused on...

August 08 2024
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
146.513.8805970149335390335263634368.69741437DE
428.58.07365439093353390320145430350.65359107DE
1252.515.9574468085329394312.5143455351.03364925DE
26186.595.641025641195394188202746300.50404791DE
5284.528.4511784512297394164.4257097239.12814544DE
156-1192.5-75.762388818315741606164.4186772445.02486195DE
260-169.5-30.76225045375511678164.4174442609.19247665DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
EMLEmmerson Plc
1.80p
(44.00%)
11.66M
LTGLearning Technologies Group Plc
96.00p
(28.17%)
7.89M
CWRCeres Power Holdings Plc
251.40p
(25.57%)
3.99M
NTVONativo Resources Plc
0.0031p
(24.00%)
3.51B
ASAIAsa International Group Plc
68.00p
(19.82%)
178.7k
CPH2Clean Power Hydrogen Plc
7.85p
(-29.91%)
3.17M
CCSCrossword Cybersecurity Plc
1.85p
(-24.49%)
1.55M
HUMHummingbird Resources Plc
6.55p
(-22.94%)
19.63M
EMEEmpyrean Energy Plc
0.25p
(-19.35%)
4.08M
VELAVela Technologies Plc
0.0055p
(-15.38%)
23.19M
NTVONativo Resources Plc
0.0031p
(24.00%)
3.51B
MSMNMosman Oil And Gas Limited
0.035p
(1.45%)
1.2B
CLONClontarf Energy Plc
0.06p
(-0.83%)
952.24M
SYMESupply@me Capital Plc
0.0042p
(-6.67%)
771.44M
UFOAlien Metals Limited
0.1075p
(-8.51%)
337.69M

Discussion

View Full Feed
LORTAP KCOTS LORTAP KCOTS 1 minute ago
I’m sure there is nothing coming, lol
EDXC
dshade dshade 1 minute ago
let it dry out and enjoy your weekend folks
CBRF
sspalmo sspalmo 1 minute ago
To be clear, I never stated that a Class Action lawsuit would be a worthwhile venture. If there is a Class Action lawsuit, I will not be participating as I have not been a shareholder since November of 2023. I was merely offering a suggestion that the James Hicks interview where Chandra enthusiast
GLD
LongBalls LongBalls 2 minutes ago
If they sell now it’s cash in their pockets. https://apple.news/Ax36PO4OMSECgvwrS9MKrWA
DJT
xstream xstream 2 minutes ago
I wonder how long it will take for the SEC to act?
RECX
StayHumble StayHumble 2 minutes ago
$DBMM litigated w/Kramer✅2Protect Shareholders +Mrktpl ✅
Asher Enterprises, Inc. has been sanctioned numerous times by the Commission for Securities §5 violations and, under information and belief, intends to commit further Securities Act §5 violations in DBMM's securit
DBMM GTII
dshade dshade 3 minutes ago
https://www.porttampawebcam.com/
CBRF
Ribo Ribo 3 minutes ago
Changes in Registrant’s Certifying Accountant.
https://ih.advfn.com/stock-market/USOTC/bowmo-ce-BOMO/stock-news/94627191/form-8-k-current-report
BOMO
SkyLimit2022 SkyLimit2022 3 minutes ago
dstock07734,

Very interesting!

The PD-1 blockade technology seems to have the biggest market share of the rapidly expanding immunotherapy market globally. Subcutaneous versions of checkpoint inhibitors are looking like a very big deal recently.

I think
NWBO
LongBalls LongBalls 3 minutes ago
Insider s selling stock at fast pace. https://apple.news/Ax36PO4OMSECgvwrS9MKrWA
DJT
Royal Dude Royal Dude 4 minutes ago
4137

09/27/2024

LETTER MOTION for Leave to File individualized supplemental memoranda of law in support of summary judgment (filed on behalf of JPMorgan, Credit Suisse, NatWest, and Norinchukin) addressed to Judge Naomi Reice Buchwald from Alan C. Turner dated September
COOP
Milesblue42 Milesblue42 4 minutes ago
cojoboy, focus on Ronn Ford's Toxic Financing deals.....

You need to focus on the FACT that you refuse to comprehend I Don't Care about anything you post...You repeatedly posting the same thing 100 x's will Never Change That..lol...Can not make this stuff up..LMFAAOOOO..!!!😂&#
RONN
lakers17 lakers17 4 minutes ago
Wow, let's see if the bozos even read it. NSAV has to turn over all accounts in and outside the US. Tilton's, NSAVs everything. Computer passwords and everything. Websites, cell phones everything. Has to be done within 5 business days. NSAV is totally under the microscope now and in deep manur
NSAV
tick talk tick talk 4 minutes ago
Have u tried a shout out to FBI or Homeland security? If you feel their us fraud here u should give a call to the protectors.go gncp$$$$
GNCP
DTGoody DTGoody 4 minutes ago
I agree 100% and feel if we go current with major funding and or partnerships, we could be looking at .10 cents going into 2025. This sucks watching this trade here on the expert market now, but I know what can happen once they get their ducks in a row.

Fingers are Crossed!!!
RSPI
ExtremelyBullishZig ExtremelyBullishZig 4 minutes ago
Smart people vaxed. Idiots rushed the capitol.
AVXL
NEnorth NEnorth 5 minutes ago
Dshade how did you fare with your boat ?? And how did the picnic Is fare ?? I saw flooding at Mcdill on news looked pretty severe ??
CBRF
back2basics back2basics 5 minutes ago
Holistically speaking, we are not going holistically back To where the children of the community are the community's children, holistically speaking.

B2B --speaking in Kamel Toe.
SSKILLZ1 SSKILLZ1 5 minutes ago
I could use some help from KC, I would like you to get your win today, while your motivated, because if I'm being honest, the twins might lose today and the point might not matter, because they really stink. And you might be in by that alone.
Lime Time Lime Time 6 minutes ago
It's amazing how little DD these people do on what makes OTC tickers move up or down. This is completely bullish with CEO owning common shares. It will go through a TSNP type run.
BCAP
1vman 1vman 6 minutes ago
*****🅰️🅰️🅰️ WOW !!! 50 billion share authorized here

PEE YEW stinky OTC pinky here

https://www.otcmarkets.com/stock/UBQU/security

ENOUGH SAID
UBQU
georgejjl georgejjl 7 minutes ago
Anavex 3-71 is more potent with less side effects than KarXT.

Good luck and GOD bless,
AVXL

Your Recent History

LSE
OXB
Oxford Biomedica
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved